These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 19201176)

  • 1. Plasma and blood viscosity in metabolic syndrome.
    Irace C; Scavelli F; Carallo C; Serra R; Gnasso A
    Nutr Metab Cardiovasc Dis; 2009 Sep; 19(7):476-80. PubMed ID: 19201176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of metabolic syndrome's components on the development of cardiovascular disease in a Jordanian cohort with metabolic syndrome.
    Haddad FH; Mahafza SM
    Saudi Med J; 2008 Sep; 29(9):1299-305. PubMed ID: 18813416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low plasma ghrelin concentration is an indicator of the metabolic syndrome.
    Ukkola O; Pöykkö SM; Antero Kesäniemi Y
    Ann Med; 2006; 38(4):274-9. PubMed ID: 16754258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma viscosity and related cardiovascular risk factors in a Spanish Mediterranean population.
    Vayá A; Simó M; Santaolaria M; Carrasco P; Corella D
    Thromb Res; 2007; 120(4):489-95. PubMed ID: 17215030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma viscosity in patients with metabolic syndrome.
    Ucak S; Basat O; Cetinkaya E
    Clin Hemorheol Microcirc; 2013 Jan; 54(1):15-22. PubMed ID: 22614764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin microcirculatory dysfunction is already present in normoglycemic subjects with metabolic syndrome.
    Kraemer-Aguiar LG; Laflor CM; Bouskela E
    Metabolism; 2008 Dec; 57(12):1740-6. PubMed ID: 19013299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight fluctuations and risk for metabolic syndrome in an adult cohort.
    Vergnaud AC; Bertrais S; Oppert JM; Maillard-Teyssier L; Galan P; Hercberg S; Czernichow S
    Int J Obes (Lond); 2008 Feb; 32(2):315-21. PubMed ID: 17968381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperuricemia and the metabolic syndrome in Hangzhou.
    Cai Z; Xu X; Wu X; Zhou C; Li D
    Asia Pac J Clin Nutr; 2009; 18(1):81-7. PubMed ID: 19329400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and high-sensitivity C-reactive protein in Cubans.
    Huffman FG; Gomez GP; Zarini GG
    Ethn Dis; 2009; 19(2):115-20. PubMed ID: 19537220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of endurance training and long distance running on blood viscosity.
    Wood SC; Doyle MP; Appenzeller O
    Med Sci Sports Exerc; 1991 Nov; 23(11):1265-9. PubMed ID: 1766342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of inflammatory markers on cardiovascular mortality in patients with metabolic syndrome.
    Espinola-Klein C; Rupprecht HJ; Bickel C; Lackner K; Genth-Zotz S; Post F; Munzel T; Blankenberg S;
    Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):278-84. PubMed ID: 18525381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of white blood cell count with metabolic syndrome in patients undergoing peritoneal dialysis.
    Park JT; Chang TI; Kim DK; Choi HY; Lee JE; Kim HW; Chang JH; Park SY; Kim E; Yoo TH; Han DS; Kang SW
    Metabolism; 2009 Oct; 58(10):1379-85. PubMed ID: 19501862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of serum lipid values in subjects with and without the metabolic syndrome.
    Cordero A; Laclaustra M; León M; Casasnovas JA; Grima A; Luengo E; Ordoñez B; Bergua C; Bes M; Pascual I; Alegría E;
    Am J Cardiol; 2008 Aug; 102(4):424-8. PubMed ID: 18678299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High sensitivity C-reactive protein is associated with the metabolic syndrome independent to viral and bacterial pathogen burden.
    Ebrahimi A; Nabipour I; Vahdat K; Jafari SM; Fouladvand M; Assadi M; Movahed A; Obeidi N; Sanjdideh Z
    Diabetes Res Clin Pract; 2009 Jun; 84(3):296-302. PubMed ID: 19362745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Children and adolescents with obesity and the metabolic syndrome have high circulating cortisol levels.
    Sen Y; Aygun D; Yilmaz E; Ayar A
    Neuro Endocrinol Lett; 2008 Feb; 29(1):141-5. PubMed ID: 18283269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma viscosity, an early cardiovascular risk factor in women with subclinical hypothyroidism.
    Erdem TY; Ercan M; Ugurlu S; Balci H; Acbay O; Gundogdu S
    Clin Hemorheol Microcirc; 2008; 38(4):219-25. PubMed ID: 18334776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma viscosity as a cardiovascular risk marker in patients with proteinuria.
    Ercan M; Konukoglu D; Onen S
    Clin Hemorheol Microcirc; 2003; 29(2):111-6. PubMed ID: 14610306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-wave duration and dispersion in patients with metabolic syndrome.
    Yasar AS; Bilen E; Bilge M; Ipek G; Ipek E; Kirbas O
    Pacing Clin Electrophysiol; 2009 Sep; 32(9):1168-72. PubMed ID: 19719494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.